Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock) - Laporan Laba Rugi (TTM)

Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock)
US ˙ NYSE

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
Revenue 202 223 278 333 409 486 461 437 455 472 542 612 575 537 505 472 428 384
Change (%) 10.16 24.63 19.77 22.94 18.66 -5.01 -5.27 4.01 3.86 14.85 12.93 -6.12 -6.52 -6.11 -6.51 -9.30 -10.25
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 207 210 262 314 428 543 564 585 605 624 669 713 664 614 583 552 508 463
Change (%) 1.36 24.78 19.86 36.40 26.69 3.92 3.77 3.37 3.26 7.12 6.65 -6.97 -7.49 -5.01 -5.27 -8.09 -8.80
% of Revenue 102.31 94.13 94.24 94.31 104.64 111.72 122.21 133.87 133.05 132.28 123.38 116.51 115.46 114.26 115.60 117.13 118.69 120.62
Gross Operating Profit -5 13 16 19 -19 -57 -102 -148 -150 -152 -127 -101 -89 -77 -79 -81 -80 -79
Change (%) -380.27 22.36 18.28 -200.24 199.76 80.07 44.47 1.49 1.46 -16.83 -20.24 -12.11 -13.78 2.72 2.65 -1.00 -1.01
% of Revenue -2.31 5.87 5.76 5.69 -4.64 -11.72 -22.21 -33.87 -33.05 -32.28 -23.38 -16.51 -15.46 -14.26 -15.60 -17.13 -18.69 -20.62
SG&A 336 321 335 350 376 401 387 372 372 373 382 392 389 386 376 366 409 453
Change (%) -4.60 4.65 4.44 7.28 6.79 -3.66 -3.80 0.08 0.08 2.65 2.58 -0.76 -0.77 -2.65 -2.72 11.90 10.63
% of Revenue 166.00 143.75 120.70 105.25 91.85 82.66 83.83 85.13 81.91 78.93 70.54 64.08 67.73 71.90 74.55 77.58 95.71 117.98
R&D
Change (%)
% of Revenue
OpEx 543 531 597 664 804 944 950 957 977 997 1,051 1,106 1,053 1,000 959 918 917 916
Change (%) -2.33 12.61 11.20 21.05 17.39 0.69 0.69 2.09 2.05 5.45 5.17 -4.77 -5.00 -4.10 -4.27 -0.12 -0.12
% of Revenue 268.31 237.89 214.94 199.57 196.49 194.38 206.04 219.00 214.96 211.22 193.92 180.59 183.19 186.15 190.15 194.70 214.40 238.60
Operating Income -341 -308 -319 -331 -395 -458 -489 -520 -523 -525 -509 -493 -478 -463 -455 -447 -489 -532
Change (%) -9.75 3.89 3.75 19.14 16.06 6.73 6.31 0.48 0.48 -3.01 -3.10 -3.09 -3.19 -1.76 -1.79 9.57 8.73
% of Revenue -168.31 -137.89 -114.94 -99.57 -96.49 -94.38 -106.04 -119.00 -114.96 -111.22 -93.92 -80.59 -83.19 -86.15 -90.15 -94.70 -114.40 -138.60
Interest Expense -61 -81 -84 -86 -80 -74 -95 -116 -118 -120 -128 -136 -151 -166 -158 -150 -172 -193
Change (%) 33.85 3.12 3.02 -7.31 -7.89 28.74 22.33 1.79 1.75 6.67 6.25 10.73 9.69 -4.74 -4.98 14.42 12.60
% of Revenue -30.03 -36.48 -30.18 -25.96 -19.57 -15.19 -20.59 -26.59 -26.02 -25.49 -23.68 -22.28 -26.27 -30.83 -31.28 -31.79 -40.11 -50.32
Net Income -303 -310 -291 -272 -271 -271 -284 -296 -393 -490 -478 -466 -382 -298 -338 -379 -344 -308
Change (%) 2.35 -6.20 -6.61 -0.02 -0.02 4.48 4.29 32.78 24.69 -2.42 -2.48 -18.06 -22.04 13.65 12.01 -9.33 -10.29
% of Revenue -149.61 -139.00 -104.61 -81.57 -66.33 -55.89 -61.47 -67.68 -86.39 -103.72 -88.13 -76.10 -66.42 -55.39 -67.05 -80.33 -80.31 -80.28

Source: Capital IQ

Other Listings
DE:C2C
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista